Почетна › Hronična limfocitna leukemija › Minesota › Rochester
Kliničke studije za Hronična limfocitna leukemija u gradu Rochester, MN
20 studija za Hronična limfocitna leukemija traži učesnike na lokacijama u gradu Rochester i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
Тражи се учесникФаза 1
- Mayo Clinic Rochester, Rochester
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Тражи се учесникФаза 3
- Mayo Clinic in Rochester, Rochester
Family Study of Lymphoproliferative Disorders
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Mayo Clinic, Rochester
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Тражи се учесникФаза 2
- Mayo Clinic in Rochester, Rochester
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Тражи се учесникФаза 1/2
- Mayo Clinic, Clinical Trials Referral Office, Rochester
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
Тражи се учесникФаза 3
- Mayo Clinic Rochester, Rochester
Wisconsin Ginseng for Decreasing Cancer Related Fatigue
Тражи се учесникФаза 3
- Mayo Clinic in Rochester, Rochester
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Тражи се учесникФаза 1/2
- Mayo Clinic Rochester, Rochester
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
Тражи се учесникФаза 1/2
- Research Site, Rochester
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Тражи се учесникФаза 3
- Mayo Clinic Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Тражи се учесникФаза 3
- Mayo Clinic Rochester, Rochester
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Тражи се учесникФаза 1/2
- Mayo Clinic, Rochester
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
Тражи се учесникФаза 2
- Mayo Clinic, Rochester
CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies
Тражи се учесникФаза 1
- Mayo Clinic in Rochester, Rochester
The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients
Тражи се учесникЗдраве особе су добродошле
- Mayo Clinic in Rochester, Rochester
Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Mayo Clinic in Rochester, Rochester
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Тражи се учесникФаза 4
- Mayo Clinic- Minnesota, Rochester
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Тражи се учесникФаза 4
- Mayo Clinic- Minnesota, Rochester
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
Тражи се учесникОпсервациона студија
- Mayo Clinic in Rochester, Rochester
Q702 for the Treatment of Patients With Hematologic Malignancies
Тражи се учесникФаза 1
- Mayo Clinic in Rochester, Rochester
Studije za Hronična limfocitna leukemija u drugim gradovima
- Boston, MA31 студија
- Columbus, OH29 студија
- Durham, NC28 студија
- Washington, DC22 студија
- Seattle, WA22 студија
- New York City, NY20 студија
- Houston, TX18 студија
- Baldwin Park, CA18 студија
- Cincinnati, OH15 студија
- Milwaukee, WI15 студија
- Chicago, IL14 студија
- Nashville, TN13 студија
Ostale studije u gradu Rochester
- Рак дојке39 студија
- Немалоклетни карцином плућа38 студија
- Рак (све врсте)31 студија
- Метастатски карцином28 студија
- Рак јајника27 студија
- Колоректални карцином27 студија
- Многи мијелом25 студија
- Затајење срца21 студија
- Рак плућа21 студија
- Рак простате20 студија
- Рак панкреаса20 студија
- Карцином ендометријума19 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.